SXC Health's (TSX:SXC) meteoric rise, accomplished primarily through acquisition, has been nothing short of remarkable. The company, which was … [Read more...] about Versant Partners: There’s Still Upside in SXC Health
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
There are many people who believe Canadian technology stocks are undervalued. Of course, as John Maynard Keynes famously quipped, markets can remain … [Read more...] about 15 Canadian Techs Trading Far Below Analyst Targets
For Vancouver's Verisante (TSXV:VRS), the waiting game is almost over. The company's skin cancer detection device, Aura, seems on the cusp of moving … [Read more...] about Cantech Letter interviews Thomas Braun of Verisante Technology
Those closely watching the TSX Venture Exchange's volume leaders lately may have noticed a new tech entry surface. Calgary's Ventripoint Diagnostics … [Read more...] about Investors connecting the dots on Ventripoint Diagnostics
There are big markets and then there are big markets. While still miniscule, revenue wise, Vancouver's EnWave (TSXV:ENW) stands on the shoulders of … [Read more...] about Cantech Letter interviews Tim Durance of EnWave
All your eggs in one basket. Most investors know innately that this is a bad strategy. Investors into life sciences stocks, where half-decade long … [Read more...] about Cantech Letter interviews Howard Verrico, CEO of Sirona Biochem
Don Cherry and Ottawa Senators owner Eugene Melnyk teaming up? Not quite. While Don Cherry is still spokesman for Cold-FX, the most famous product of … [Read more...] about Valeant to acquire Afexa Life Sciences. A win, win, win situation?
When it comes to spending money, nobody does it quite like the biotech sector. The Texas Hold-Em style gamble of waiting to see if your particular … [Read more...] about Canada’s Biotech Stocks. Who’s got the Cash?
After a tough few years, 2011 is shaping up quite nicely for shareholders of Quebec City's Aeterna Zentaris (TSX:AEZ). Today, nearly eight years … [Read more...] about Eight is Enough for AEterna Zentaris; granted European patent for Perifosine
Things are changing quickly in the world of fish-farming. For proof you need look no further than the man voted "Canada's most trusted Canadian" in a … [Read more...] about 5 Questions with Richard Buchanan of Agrimarine (TSXV:FSH)